Friday 6 November 2026 Export STE’s income statement to Excel — free account

STERIS plc

STE Healthcare Medical Devices

STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025.

Revenue: +8.79%
EPS: +12.8%
Free cash flow: +43.6%
Total debt: −0.21%

Quarter to September 2026, against a year earlier

251.44 2.68 −1.05%

Follow STE

Alert me

Market cap: $24.8B
P/E: 30.0×
Fwd P/E: 25.1×
Dividend yield: 1.02%
F-score: 9/9
Altman Z: 5.10
Beneish M: −2.68
Dividend safety: 86/100

Overview Business Profile Earnings & Analysis Valuation Filings

STERIS plc 10-Q filed Aug 7, 2025

Fiscal Q1 2026 · Period ended Jun 30, 2025 · Filed Aug 7, 2025 · accepted 4:04 PM ET · Document on sec.gov · Filing index

What changed

Part I, Item 2, Management’s Discussion and Analysis Part II, Item 1A, Risk Factors

Part I, Item 2, Management’s Discussion and Analysis: no comparison — no earlier filing on file